Screening and analysis of influencing factors for comorbidity of chronic glaucoma with depression and anxiety

Table 1 Comparison of clinical data between the comorbid anxiety-depression group and the non-comorbid group, n (%)/mean ± SD

Group		Depression-anxiety comorbidity group (n = 61)	Non-comorbidity group (n = 159)	t/χ2/Z	P value
Gender	Male	21 (34.43)	83 (52.20)	5.588	0.023
	Female	40 (65.57)	76 (47.80)
Age	< 40 years	2 (3.28)	44 (27.67)	17.838	0.000
	40-60 years	24 (39.34)	59 (37.11)
	> 60 years	35 (57.38)	56 (35.22)
Type	Angle-closure	33 (54.10)	76 (47.80)	0.700	0.453
	Open-angle	28 (45.90)	83 (52.20)
Living environment	Urban	49 (80.33)	62 (38.99)	30.131	0.000
	Rural	12 (19.67)	97 (61.01)
Education level	High school or below	51 (83.61)	96 (60.38)	10.729	0.001
	Above high school	10 (16.39)	63 (39.62)
Monthly household income	≤ 3000 yuan/month	45 (73.77)	67 (42.14)	17.651	0.000
	> 3000 yuan/month	16 (26.23)	92 (57.86)
Best corrected visual acuity		0.61 ± 0.16	0.70 ± 0.13	4.456	0.000
Intraocular pressure (mmHg)		15.02 ± 3.01	14.90 ± 3.04	0.284	0.777
Disease duration	< 10 years	15 (24.59)	99 (62.26)	25.062	0.000
	≥ 10 years	46 (75.41)	60 (37.74)
Surgical history	Surgery group	32 (52.46)	86 (54.09)	0.047	0.880
	Non-surgery group	29 (47.54)	73 (45.91)
Types of topical eye drops	≥ 1 type	41 (67.21)	103 (64.78)	0.115	0.755
	< 1 type	20 (32.79)	56 (35.22)
Visual field defect stage	Early stage	11 (18.03)	97 (61.01)	35.908	0.000
	Moderate stage	28 (45.90)	44 (27.67)
	Advanced stage	22 (36.07)	18 (11.32)